Why the study?
Despite poor cardiovascular outcomes, no dedicated, validated risk stratification tools exist to guide investigation or treatment in type 2 myocardial infarction.
Does the T2-risk score improve prediction of death or future myocardial infarction in patients with type 2 myocardial infarction compared to the GRACE 2.0 risk score?
Population
1,121 derivation, 250 single-center, and 253 multicenter validation patients with type 2 myocardial infarction
Comparison
T2-risk score vs Global Registry of Acute Coronary Events 2.0 risk score
Design
Prospective cohort derivation and validation study
Follow-up
1 year
Authors
Loading...
May aid risk stratification in type 2 MI; leaves open whether adoption improves outcomes or warrants prospective trials.
Does the T2-risk score improve prediction of death or future myocardial infarction in patients with type 2 myocardial infarction compared to the GRACE 2.0 risk score?
The T2-risk score provides a validated, dedicated tool with good discrimination for predicting 1-year death or MI in patients with type 2 myocardial infarction, outperforming the GRACE 2.0 score.
Taggart et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: